Epidermal growth factor receptor tyrosine kinase (EGFR‑TK) mutation testing is indicated in adults with previously untreated, locally advanced or metastatic non-small-cell lung cancer (NSCLC).

Cancer treatment has evolved from a generalised approach to a more precise one. Advances in precision medicine have transformed the way oncologists diagnose, stage, and treat cancer. At the core of ...